Academic Journal
Population Pharmacokinetic–Pharmacodynamic Modeling of Granulocyte Colony‐Stimulating Factor to Optimize Dosing and Timing for CD34 + Cell Harvesting
العنوان: | Population Pharmacokinetic–Pharmacodynamic Modeling of Granulocyte Colony‐Stimulating Factor to Optimize Dosing and Timing for CD34 + Cell Harvesting |
---|---|
المؤلفون: | Jiang, Xu, Cha, Jun Seok, Jin, Byung Hak, Kim, Choon Ok, Chae, Dongwoo |
المصدر: | Clinical and Translational Science ; volume 18, issue 1 ; ISSN 1752-8054 1752-8062 |
بيانات النشر: | Wiley |
سنة النشر: | 2025 |
المجموعة: | Wiley Online Library (Open Access Articles via Crossref) |
الوصف: | Granulocyte colony‐stimulating factor (G‐CSF) mobilizes peripheral blood (PB) progenitor cells from bone marrow (BM) into circulation for PB stem cell transplantation (PBSCT). This study aimed to develop a population pharmacokinetic–pharmacodynamic (PK‐PD) model of filgrastim in healthy subjects to optimize PB CD34 + cell collection. Plasma filgrastim concentrations and CD34 + cell count data were obtained from a clinical study involving healthy Korean subjects. A total of 1378 plasma concentration measurements and 982 CD34 + cell count data collected from 53 subjects were used in the PK‐PD model. Filgrastim PKs were adequately described by a one‐compartment linear disposition model with an additional transit compartment for absorption. Log‐transformed body weight was the only significant covariate affecting the volume of distribution and clearance. CD34 + cell mobilization was best captured by a modified Friberg model, assuming continual entry of proliferating BM stem cells into PB via a single transit compartment. Simulation results suggested that the 5 μg/kg twice‐daily dosing regimen may yield higher CD34 + cell counts compared to the 10 μg/kg once‐daily regimen for achieving target CD34 + cell counts of 20/μL and 50/μL. We successfully developed a robust PK‐PD model of G‐CSF that optimizes the yield of CD34 + cells during allogeneic PBSCT. This model can guide the efficient determination of optimal G‐CSF dosing regimens and CD34 + cell harvesting strategies. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1111/cts.70121 |
الاتاحة: | https://doi.org/10.1111/cts.70121 https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1111/cts.70121 |
Rights: | http://creativecommons.org/licenses/by-nc/4.0/ |
رقم الانضمام: | edsbas.6B69954E |
قاعدة البيانات: | BASE |
ResultId |
1 |
---|---|
Header |
edsbas BASE edsbas.6B69954E 1057 3 Academic Journal academicJournal 1056.5498046875 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.6B69954E&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doi.org/10.1111/cts.70121# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Population Pharmacokinetic–Pharmacodynamic Modeling of Granulocyte Colony‐Stimulating Factor to Optimize Dosing and Timing for CD34 + Cell Harvesting
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Jiang%2C+Xu%22">Jiang, Xu</searchLink><br /><searchLink fieldCode="AR" term="%22Cha%2C+Jun+Seok%22">Cha, Jun Seok</searchLink><br /><searchLink fieldCode="AR" term="%22Jin%2C+Byung+Hak%22">Jin, Byung Hak</searchLink><br /><searchLink fieldCode="AR" term="%22Kim%2C+Choon+Ok%22">Kim, Choon Ok</searchLink><br /><searchLink fieldCode="AR" term="%22Chae%2C+Dongwoo%22">Chae, Dongwoo</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Clinical and Translational Science ; volume 18, issue 1 ; ISSN 1752-8054 1752-8062 ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Wiley ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2025 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Wiley Online Library (Open Access Articles via Crossref) ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Granulocyte colony‐stimulating factor (G‐CSF) mobilizes peripheral blood (PB) progenitor cells from bone marrow (BM) into circulation for PB stem cell transplantation (PBSCT). This study aimed to develop a population pharmacokinetic–pharmacodynamic (PK‐PD) model of filgrastim in healthy subjects to optimize PB CD34 + cell collection. Plasma filgrastim concentrations and CD34 + cell count data were obtained from a clinical study involving healthy Korean subjects. A total of 1378 plasma concentration measurements and 982 CD34 + cell count data collected from 53 subjects were used in the PK‐PD model. Filgrastim PKs were adequately described by a one‐compartment linear disposition model with an additional transit compartment for absorption. Log‐transformed body weight was the only significant covariate affecting the volume of distribution and clearance. CD34 + cell mobilization was best captured by a modified Friberg model, assuming continual entry of proliferating BM stem cells into PB via a single transit compartment. Simulation results suggested that the 5 μg/kg twice‐daily dosing regimen may yield higher CD34 + cell counts compared to the 10 μg/kg once‐daily regimen for achieving target CD34 + cell counts of 20/μL and 50/μL. We successfully developed a robust PK‐PD model of G‐CSF that optimizes the yield of CD34 + cells during allogeneic PBSCT. This model can guide the efficient determination of optimal G‐CSF dosing regimens and CD34 + cell harvesting strategies. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1111/cts.70121 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1111/cts.70121<br />https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1111/cts.70121 ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => http://creativecommons.org/licenses/by-nc/4.0/ ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.6B69954E ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1111/cts.70121
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Population Pharmacokinetic–Pharmacodynamic Modeling of Granulocyte Colony‐Stimulating Factor to Optimize Dosing and Timing for CD34 + Cell Harvesting
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jiang, Xu
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Cha, Jun Seok
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jin, Byung Hak
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kim, Choon Ok
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Chae, Dongwoo
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2025
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsbas.oa
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Clinical and Translational Science ; volume 18, issue 1 ; ISSN 1752-8054 1752-8062
[Type] => main
)
)
)
)
)
)
)
|
IllustrationInfo |